Examinant per Autoria "Naves, Andrea"
Mostrant 1 - 1 de 1
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach(Impact Journals, 2021) Carcereny, Enric; Fernández Nistal, Alonso; López, Araceli; Montoto, Carmen; Naves, Andrea; Segú-Vergés, Cristina; Coma Camprodón, Mireia; Jorba Argemí, Guillem; Oliva Miguel, Baldomero; Mas, José Manuel